Zekuan Xu

15.2k total citations · 4 hit papers
193 papers, 9.5k citations indexed

About

Zekuan Xu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Zekuan Xu has authored 193 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Molecular Biology, 70 papers in Cancer Research and 42 papers in Oncology. Recurrent topics in Zekuan Xu's work include Cancer-related molecular mechanisms research (32 papers), MicroRNA in disease regulation (31 papers) and RNA modifications and cancer (29 papers). Zekuan Xu is often cited by papers focused on Cancer-related molecular mechanisms research (32 papers), MicroRNA in disease regulation (31 papers) and RNA modifications and cancer (29 papers). Zekuan Xu collaborates with scholars based in China, United States and South Korea. Zekuan Xu's co-authors include Jianghao Xu, Xuan Zhang, Lu Zhang, Lu Wang, Yi Zhang, Hao Xu, Bowen Li, Zheng Chen, Li Yang and Weizhi Wang and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.

In The Last Decade

Zekuan Xu

184 papers receiving 9.4k citations

Hit Papers

The Role of Tumoral FOXP3 on Cell Proliferation, Migratio... 2017 2026 2020 2023 2017 2019 2019 2022 500 1000 1.5k 2.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zekuan Xu China 47 5.4k 3.8k 2.1k 2.0k 1.3k 193 9.5k
Kazuyoshi Yanagihara Japan 49 5.0k 0.9× 1.7k 0.4× 864 0.4× 2.2k 1.1× 1.1k 0.8× 215 7.8k
Hiromu Suzuki Japan 57 9.6k 1.8× 3.3k 0.9× 692 0.3× 2.6k 1.3× 1.2k 0.9× 243 12.4k
Hiroshi Yokozaki Japan 62 6.1k 1.1× 1.9k 0.5× 1.7k 0.8× 4.1k 2.1× 1.7k 1.4× 305 12.0k
Xiubao Ren China 48 3.9k 0.7× 2.2k 0.6× 3.3k 1.6× 3.7k 1.9× 919 0.7× 245 8.6k
Murray B. Resnick United States 44 2.2k 0.4× 1.1k 0.3× 1.2k 0.6× 2.1k 1.1× 1.2k 0.9× 174 6.7k
Iris Barshack Israel 46 3.3k 0.6× 1.6k 0.4× 1.3k 0.6× 1.6k 0.8× 798 0.6× 258 8.1k
Bence Sipos Germany 58 4.8k 0.9× 2.1k 0.6× 1.7k 0.8× 5.6k 2.8× 748 0.6× 205 10.9k
Eleonora Candi Italy 55 5.9k 1.1× 2.4k 0.6× 1.0k 0.5× 2.7k 1.4× 1.3k 1.0× 202 11.0k
Yuan Yuan China 37 2.9k 0.5× 1.6k 0.4× 672 0.3× 664 0.3× 934 0.7× 348 5.5k
Norimasa Sawada Japan 53 3.8k 0.7× 1.4k 0.4× 765 0.4× 1.4k 0.7× 789 0.6× 214 8.8k

Countries citing papers authored by Zekuan Xu

Since Specialization
Citations

This map shows the geographic impact of Zekuan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zekuan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zekuan Xu more than expected).

Fields of papers citing papers by Zekuan Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zekuan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zekuan Xu. The network helps show where Zekuan Xu may publish in the future.

Co-authorship network of co-authors of Zekuan Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Zekuan Xu. A scholar is included among the top collaborators of Zekuan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zekuan Xu. Zekuan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fang, Lang, Jialun Lv, Penghui Xu, et al.. (2025). YBX1 promotes 5-Fluorouracil resistance in gastric cancer via m5C-dependent ATG9A mRNA stabilization through autophagy. Oncogene. 44(28). 2357–2371. 3 indexed citations
2.
Xu, Yihan, Yi Li, Weiming Zhu, et al.. (2025). Impact of Sarcopenic Obesity on Postoperative Outcomes in Patients With IBD After Bowel Resection Surgery: A Retrospective Cohort Study. Diseases of the Colon & Rectum. 69(1). 53–63.
3.
4.
Xiao, Jian, Jiawei Wang, Pengyu Li, et al.. (2024). Leptin‐mediated suppression of lipoprotein lipase cleavage enhances lipid uptake and facilitates lymph node metastasis in gastric cancer. Cancer Communications. 44(8). 855–878. 10 indexed citations
5.
Xiao, Jian, et al.. (2023). Prognostic Value of Tumor Size in Gastric Cancer: A Retrospective Cohort Study Based on SEER Database. International Journal of Surgical Pathology. 31(7). 1273–1282. 3 indexed citations
6.
Li, Ying, Yiwen Xia, Tianlu Jiang, et al.. (2023). Long noncoding RNA DIAPH2-AS1 promotes neural invasion of gastric cancer via stabilizing NSUN2 to enhance the m5C modification of NTN1. Cell Death and Disease. 14(4). 260–260. 31 indexed citations
7.
Xu, Penghui, Jing Yang, Zetian Chen, et al.. (2023). N6‐methyladenosine modification of CENPF mRNA facilitates gastric cancer metastasis via regulating FAK nuclear export. Cancer Communications. 43(6). 685–705. 20 indexed citations
8.
Xu, Hao, Weizhi Wang, Zhongyuan He, et al.. (2023). Evaluation of neoadjuvant immunotherapy plus chemotherapy in Chinese surgically resectable gastric cancer: a pilot study by meta-analysis. Frontiers in Immunology. 14. 1193614–1193614. 14 indexed citations
10.
Jiang, Tianlu, Yiwen Xia, Ying Li, et al.. (2023). TRIM29 promotes antitumor immunity through enhancing IGF2BP1 ubiquitination and subsequent PD-L1 downregulation in gastric cancer. Cancer Letters. 581. 216510–216510. 32 indexed citations
11.
Liu, Zonghang, Zhongyuan He, Bowen Li, et al.. (2023). Deubiquitylation of Rab35 by USP32 promotes the transmission of imatinib resistance by enhancing exosome secretion in gastrointestinal stromal tumours. Oncogene. 42(12). 894–910. 18 indexed citations
12.
13.
Peng, Rui, Wenhua You, Chupeng Hu, et al.. (2022). Gastric Microbiome Alterations Are Associated with Decreased CD8+ Tissue-Resident Memory T Cells in the Tumor Microenvironment of Gastric Cancer. Cancer Immunology Research. 10(10). 1224–1240. 93 indexed citations
14.
Chen, Lu, Dawei Rong, Bingqing Hui, et al.. (2021). CircETFA upregulates CCL5 by sponging miR-612 and recruiting EIF4A3 to promote hepatocellular carcinoma. Cell Death Discovery. 7(1). 321–321. 23 indexed citations
15.
Fan, Hao, Yugang Ge, Xiang Ma, et al.. (2020). Long non-coding RNA CCDC144NL-AS1 sponges miR-143-3p and regulates MAP3K7 by acting as a competing endogenous RNA in gastric cancer. Cell Death and Disease. 11(7). 521–521. 36 indexed citations
16.
Zhang, Qiang, Jianghao Xu, Yi Qian, et al.. (2018). Association of Imatinib Plasma Concentration and Single-nucleotide Polymorphisms with Adverse Drug Reactions in Patients with Gastrointestinal Stromal Tumors. Molecular Cancer Therapeutics. 17(12). 2780–2787. 23 indexed citations
17.
Chen, Zheng, Zheng Li, Mohammed Soutto, et al.. (2018). Integrated Analysis of Mouse and Human Gastric Neoplasms Identifies Conserved microRNA Networks in Gastric Carcinogenesis. Gastroenterology. 156(4). 1127–1139.e8. 36 indexed citations
18.
Xu, Zekuan & Zheng Li. (2018). [Feasibility and efficacy of laparoscopic treatment for advanced gastric cancer from LOC-A study].. PubMed. 21(10). 1103–1105. 1 indexed citations
19.
Xu, Hao, Liang Chen, Yang Shao, et al.. (2017). Clinical Application of Circulating Tumor DNA in the Genetic Analysis of Patients with Advanced GIST. Molecular Cancer Therapeutics. 17(1). 290–296. 27 indexed citations
20.
Xu, Hao, Weizhi Wang, Panyuan Li, et al.. (2017). [The key points of prevention for special surgical complications after radical operation of gastric cancer].. PubMed. 20(2). 152–155. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026